Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers [Phase 1]
Phase I clinical trial update for the radiopharmaceutical [68Ga]Ga-DWJ155 in patients with breast cancer and non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of ABBV-927 in combination with ABBV-368, Budigal…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
Describes a planned clinical trial evaluating a perioperative comprehensive diagnosis and treatment system for lung cancer in the era of neo…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC [Phase 3]
Phase 3 trial of adjuvant durvalumab (MEDI4736) in completely resected non-small cell lung cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm [NA]
This ClinicalTrials.gov entry describes a recruiting study from Fudan University evaluating selective lymph node resection for invasive non-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the bioavailability of subcutaneously administered tislelizumab for first-line treatment of advanced or metastati…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update investigating CD8+ T cell imaging during treatment in patients with non-small cell lung cancer, currently recr…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) [Phase 1]
Phase 1 study to evaluate the safety, tolerability, and efficacy of TMT101 injection as monotherapy in patients with advanced pancreatic can…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
An exploratory observational study examining the relationships between inflammation, cachexia, and therapeutic response in non-small cell lu…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: AI-Based Prediction of Stage and Survival in Non-Small Cell Lung Cancer: A Retrospective Study
This clinical trial update describes a retrospective study using AI to predict cancer stage and survival in non-small cell lung cancer. The …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy [Phase 3]
Phase 3 trial evaluating ASKC202 in combination with Limertinib versus platinum-based chemotherapy for locally advanced or metastatic non-sm…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC [Phase 1]
Phase 1 randomized trial evaluating glutathione in combination with an anti-PD-1 antibody and chemotherapy for advanced non-small cell lung …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase II, single-center trial is evaluating the combination of sacituzumab tirumotecan with tagitanlimab as neoadjuvant therapy for PD-L1-…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer [Phase 1]
A Phase 1 clinical trial update for BT02 in advanced lung cancer, including Non-Small Cell Lung Cancer and Small Cell Lung Cancer, with stat…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study [NA]
A randomized controlled study evaluating an AI-based DeepGEM tool to predict gene mutations in Non-small cell lung cancer patients; the tria…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy [Phase 2]
A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy as adjuvant therapy for stage IB-IIIB non-small cell lung c…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients [Phase 2]
Phase 2 clinical study evaluating HLX26 in combination with Serplulimab and chemotherapy in previously untreated advanced non-small cell lun…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: AI Models for Predicting Occult Pleural Dissemination in NSCLC
Clinical trial investigating AI models to predict occult pleural dissemination in non-small cell lung cancer has completed. The study was sp…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer
This document reports a clinical trial investigating AI-driven risk and prognosis assessment for brain metastases in non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC [NA]
This study analyzes the biological characteristics of advanced ALK-rearranged non-small cell lung cancer. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-04Clinical Trial Update: Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
An observational prospective study (OBSTINATE) evaluating quality of life in patients with unresectable TNM stage III non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-08-04Clinical Trial Update: Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion [NA]
An update on a clinical trial investigating how resistance to amivantamab may develop in non-small cell lung cancer patients with EGFR exon …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer [Phase 1, Phase 2]
This update describes an ongoing Phase 1/2 study of BL-M07D1 in patients with HER2-mutated, locally advanced or metastatic non-small-cell lu…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Inupadenant (EOS100850) with chemotherapy as second-line treatment for nonsquamous non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of OBI-833/OBI-821 with first-line erlotinib in EGFR-mutant, Globo H-positive locally adva…